Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection

✍ Scribed by James F. Cummings; Michele D. Spring; Robert J. Schwenk; Christian F. Ockenhouse; Kent E. Kester; Mark E. Polhemus; Douglas S. Walsh; In-Kyu Yoon; Christine Prosperi; Laure Y. Juompan; David E. Lanar; Urszula Krzych; B. Ted Hall; Lisa A. Ware; V. Ann Stewart; Jack Williams; Megan Dowler; Robin K. Nielsen; Collette J. Hillier; Birgitte K. Giersing; Filip Dubovsky; Elissa Malkin; Kathryn Tucker; Marie-Claude Dubois; Joe D. Cohen; W. Ripley Ballou; D. Gray Heppner Jr

• Book ID: 116961937
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 555 KB
• Volume: 28
• Category: Article
• ISSN: 0264-410X
• DOI: 10.1016/j.vaccine.2009.08.046